nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—Lisdexamfetamine—Lisinopril—systemic scleroderma	0.36	1	CrCrCtD
Selegiline—CYP2C8—Mometasone—systemic scleroderma	0.0737	0.194	CbGbCtD
Selegiline—CYP1A2—Pentoxifylline—systemic scleroderma	0.0385	0.102	CbGbCtD
Selegiline—CYP1A2—Leflunomide—systemic scleroderma	0.0367	0.097	CbGbCtD
Selegiline—ABCB1—Lisinopril—systemic scleroderma	0.0337	0.0889	CbGbCtD
Selegiline—CYP2C9—Leflunomide—systemic scleroderma	0.0331	0.0874	CbGbCtD
Selegiline—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0293	0.0774	CbGbCtD
Selegiline—ABCB1—Captopril—systemic scleroderma	0.0252	0.0666	CbGbCtD
Selegiline—CYP2D6—Captopril—systemic scleroderma	0.0238	0.0627	CbGbCtD
Selegiline—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0198	0.0524	CbGbCtD
Selegiline—CYP2C19—Prednisone—systemic scleroderma	0.0197	0.0519	CbGbCtD
Selegiline—ABCB1—Prednisone—systemic scleroderma	0.0159	0.0419	CbGbCtD
Selegiline—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0119	0.0314	CbGbCtD
Selegiline—CYP3A4—Prednisone—systemic scleroderma	0.00951	0.0251	CbGbCtD
Selegiline—ABCB1—Methotrexate—systemic scleroderma	0.00796	0.021	CbGbCtD
Selegiline—CYP2C9—cardial valve—systemic scleroderma	0.00396	0.461	CbGeAlD
Selegiline—MAOB—connective tissue—systemic scleroderma	0.000351	0.0408	CbGeAlD
Selegiline—MAOA—connective tissue—systemic scleroderma	0.000299	0.0348	CbGeAlD
Selegiline—CYP2A6—lung—systemic scleroderma	0.000287	0.0334	CbGeAlD
Selegiline—MAOB—digestive system—systemic scleroderma	0.000253	0.0295	CbGeAlD
Selegiline—ABCB1—blood vessel—systemic scleroderma	0.00025	0.0291	CbGeAlD
Selegiline—MAOB—tendon—systemic scleroderma	0.000241	0.0281	CbGeAlD
Selegiline—CYP2C19—digestive system—systemic scleroderma	0.000221	0.0257	CbGeAlD
Selegiline—MAOA—digestive system—systemic scleroderma	0.000216	0.0252	CbGeAlD
Selegiline—CYP2B6—skin of body—systemic scleroderma	0.000216	0.0252	CbGeAlD
Selegiline—MAOB—lung—systemic scleroderma	0.000212	0.0246	CbGeAlD
Selegiline—MAOA—tendon—systemic scleroderma	0.000206	0.024	CbGeAlD
Selegiline—MAOA—lung—systemic scleroderma	0.000181	0.021	CbGeAlD
Selegiline—CYP1A2—digestive system—systemic scleroderma	0.00018	0.021	CbGeAlD
Selegiline—CYP2B6—digestive system—systemic scleroderma	0.000173	0.0201	CbGeAlD
Selegiline—CYP2C9—digestive system—systemic scleroderma	0.000171	0.0199	CbGeAlD
Selegiline—CYP2E1—digestive system—systemic scleroderma	0.000162	0.0189	CbGeAlD
Selegiline—CYP2E1—tendon—systemic scleroderma	0.000154	0.018	CbGeAlD
Selegiline—CYP1A2—lung—systemic scleroderma	0.000151	0.0175	CbGeAlD
Selegiline—CYP2B6—lung—systemic scleroderma	0.000144	0.0168	CbGeAlD
Selegiline—CYP2E1—lung—systemic scleroderma	0.000135	0.0158	CbGeAlD
Selegiline—CYP3A4—digestive system—systemic scleroderma	0.000131	0.0152	CbGeAlD
Selegiline—CYP2D6—digestive system—systemic scleroderma	0.000128	0.015	CbGeAlD
Selegiline—ABCB1—digestive system—systemic scleroderma	9.24e-05	0.0108	CbGeAlD
Selegiline—Palpitations—Mycophenolate mofetil—systemic scleroderma	8.33e-05	0.00033	CcSEcCtD
Selegiline—Weight decreased—Prednisone—systemic scleroderma	8.3e-05	0.000328	CcSEcCtD
Selegiline—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	8.29e-05	0.000328	CcSEcCtD
Selegiline—Hyperglycaemia—Prednisone—systemic scleroderma	8.27e-05	0.000327	CcSEcCtD
Selegiline—Cough—Mycophenolate mofetil—systemic scleroderma	8.23e-05	0.000325	CcSEcCtD
Selegiline—Hypotension—Lisinopril—systemic scleroderma	8.21e-05	0.000325	CcSEcCtD
Selegiline—Dizziness—Captopril—systemic scleroderma	8.2e-05	0.000324	CcSEcCtD
Selegiline—Liver function test abnormal—Methotrexate—systemic scleroderma	8.19e-05	0.000324	CcSEcCtD
Selegiline—Convulsion—Mycophenolate mofetil—systemic scleroderma	8.17e-05	0.000323	CcSEcCtD
Selegiline—Depression—Prednisone—systemic scleroderma	8.15e-05	0.000323	CcSEcCtD
Selegiline—Hypertension—Mycophenolate mofetil—systemic scleroderma	8.14e-05	0.000322	CcSEcCtD
Selegiline—Urticaria—Leflunomide—systemic scleroderma	8.12e-05	0.000321	CcSEcCtD
Selegiline—Body temperature increased—Leflunomide—systemic scleroderma	8.08e-05	0.00032	CcSEcCtD
Selegiline—Abdominal pain—Leflunomide—systemic scleroderma	8.08e-05	0.00032	CcSEcCtD
Selegiline—Acute coronary syndrome—Prednisone—systemic scleroderma	8.06e-05	0.000319	CcSEcCtD
Selegiline—Feeling abnormal—Mycophenolic acid—systemic scleroderma	8.03e-05	0.000318	CcSEcCtD
Selegiline—Arthralgia—Mycophenolate mofetil—systemic scleroderma	8.03e-05	0.000317	CcSEcCtD
Selegiline—Myalgia—Mycophenolate mofetil—systemic scleroderma	8.03e-05	0.000317	CcSEcCtD
Selegiline—Chest pain—Mycophenolate mofetil—systemic scleroderma	8.03e-05	0.000317	CcSEcCtD
Selegiline—Neuropathy peripheral—Prednisone—systemic scleroderma	8.02e-05	0.000317	CcSEcCtD
Selegiline—Myocardial infarction—Prednisone—systemic scleroderma	8.02e-05	0.000317	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	8e-05	0.000316	CcSEcCtD
Selegiline—Anxiety—Mycophenolate mofetil—systemic scleroderma	8e-05	0.000316	CcSEcCtD
Selegiline—Hypersensitivity—Azathioprine—systemic scleroderma	7.97e-05	0.000315	CcSEcCtD
Selegiline—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	7.97e-05	0.000315	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	7.97e-05	0.000315	CcSEcCtD
Selegiline—Insomnia—Lisinopril—systemic scleroderma	7.94e-05	0.000314	CcSEcCtD
Selegiline—Discomfort—Mycophenolate mofetil—systemic scleroderma	7.93e-05	0.000314	CcSEcCtD
Selegiline—Paraesthesia—Lisinopril—systemic scleroderma	7.88e-05	0.000312	CcSEcCtD
Selegiline—Vomiting—Captopril—systemic scleroderma	7.88e-05	0.000312	CcSEcCtD
Selegiline—Dry mouth—Mycophenolate mofetil—systemic scleroderma	7.85e-05	0.00031	CcSEcCtD
Selegiline—Dyspnoea—Lisinopril—systemic scleroderma	7.83e-05	0.00031	CcSEcCtD
Selegiline—Rash—Captopril—systemic scleroderma	7.82e-05	0.000309	CcSEcCtD
Selegiline—Dermatitis—Captopril—systemic scleroderma	7.81e-05	0.000309	CcSEcCtD
Selegiline—Somnolence—Lisinopril—systemic scleroderma	7.81e-05	0.000309	CcSEcCtD
Selegiline—Headache—Captopril—systemic scleroderma	7.77e-05	0.000307	CcSEcCtD
Selegiline—Confusional state—Mycophenolate mofetil—systemic scleroderma	7.76e-05	0.000307	CcSEcCtD
Selegiline—Dyspepsia—Lisinopril—systemic scleroderma	7.73e-05	0.000306	CcSEcCtD
Selegiline—ABCB1—lung—systemic scleroderma	7.72e-05	0.00899	CbGeAlD
Selegiline—Abdominal pain—Mycophenolic acid—systemic scleroderma	7.71e-05	0.000305	CcSEcCtD
Selegiline—Body temperature increased—Mycophenolic acid—systemic scleroderma	7.71e-05	0.000305	CcSEcCtD
Selegiline—Oedema—Mycophenolate mofetil—systemic scleroderma	7.69e-05	0.000304	CcSEcCtD
Selegiline—Asthma—Methotrexate—systemic scleroderma	7.66e-05	0.000303	CcSEcCtD
Selegiline—Infection—Mycophenolate mofetil—systemic scleroderma	7.64e-05	0.000302	CcSEcCtD
Selegiline—Decreased appetite—Lisinopril—systemic scleroderma	7.63e-05	0.000302	CcSEcCtD
Selegiline—Eosinophilia—Methotrexate—systemic scleroderma	7.59e-05	0.0003	CcSEcCtD
Selegiline—Gastrointestinal disorder—Lisinopril—systemic scleroderma	7.58e-05	0.0003	CcSEcCtD
Selegiline—Fatigue—Lisinopril—systemic scleroderma	7.57e-05	0.000299	CcSEcCtD
Selegiline—Shock—Mycophenolate mofetil—systemic scleroderma	7.57e-05	0.000299	CcSEcCtD
Selegiline—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	7.54e-05	0.000298	CcSEcCtD
Selegiline—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	7.53e-05	0.000298	CcSEcCtD
Selegiline—Hypersensitivity—Leflunomide—systemic scleroderma	7.53e-05	0.000298	CcSEcCtD
Selegiline—Constipation—Lisinopril—systemic scleroderma	7.51e-05	0.000297	CcSEcCtD
Selegiline—Pain—Lisinopril—systemic scleroderma	7.51e-05	0.000297	CcSEcCtD
Selegiline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	7.51e-05	0.000297	CcSEcCtD
Selegiline—Skin disorder—Mycophenolate mofetil—systemic scleroderma	7.47e-05	0.000296	CcSEcCtD
Selegiline—Bradycardia—Prednisone—systemic scleroderma	7.47e-05	0.000296	CcSEcCtD
Selegiline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	7.44e-05	0.000294	CcSEcCtD
Selegiline—Diarrhoea—Azathioprine—systemic scleroderma	7.4e-05	0.000293	CcSEcCtD
Selegiline—Nausea—Captopril—systemic scleroderma	7.36e-05	0.000291	CcSEcCtD
Selegiline—Anorexia—Mycophenolate mofetil—systemic scleroderma	7.33e-05	0.00029	CcSEcCtD
Selegiline—Asthenia—Leflunomide—systemic scleroderma	7.33e-05	0.00029	CcSEcCtD
Selegiline—Hallucination—Prednisone—systemic scleroderma	7.3e-05	0.000289	CcSEcCtD
Selegiline—Feeling abnormal—Lisinopril—systemic scleroderma	7.24e-05	0.000286	CcSEcCtD
Selegiline—Pruritus—Leflunomide—systemic scleroderma	7.23e-05	0.000286	CcSEcCtD
Selegiline—Hypotension—Mycophenolate mofetil—systemic scleroderma	7.19e-05	0.000284	CcSEcCtD
Selegiline—Gastrointestinal pain—Lisinopril—systemic scleroderma	7.18e-05	0.000284	CcSEcCtD
Selegiline—Dysuria—Methotrexate—systemic scleroderma	7.17e-05	0.000283	CcSEcCtD
Selegiline—Dizziness—Azathioprine—systemic scleroderma	7.16e-05	0.000283	CcSEcCtD
Selegiline—Erectile dysfunction—Methotrexate—systemic scleroderma	7.06e-05	0.000279	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	7.01e-05	0.000277	CcSEcCtD
Selegiline—Photosensitivity reaction—Methotrexate—systemic scleroderma	7e-05	0.000277	CcSEcCtD
Selegiline—Asthenia—Mycophenolic acid—systemic scleroderma	6.99e-05	0.000277	CcSEcCtD
Selegiline—Diarrhoea—Leflunomide—systemic scleroderma	6.99e-05	0.000277	CcSEcCtD
Selegiline—Urticaria—Lisinopril—systemic scleroderma	6.98e-05	0.000276	CcSEcCtD
Selegiline—Insomnia—Mycophenolate mofetil—systemic scleroderma	6.96e-05	0.000275	CcSEcCtD
Selegiline—Body temperature increased—Lisinopril—systemic scleroderma	6.94e-05	0.000275	CcSEcCtD
Selegiline—Abdominal pain—Lisinopril—systemic scleroderma	6.94e-05	0.000275	CcSEcCtD
Selegiline—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	6.91e-05	0.000273	CcSEcCtD
Selegiline—Pruritus—Mycophenolic acid—systemic scleroderma	6.9e-05	0.000273	CcSEcCtD
Selegiline—Vomiting—Azathioprine—systemic scleroderma	6.88e-05	0.000272	CcSEcCtD
Selegiline—Pneumonia—Methotrexate—systemic scleroderma	6.87e-05	0.000272	CcSEcCtD
Selegiline—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	6.86e-05	0.000271	CcSEcCtD
Selegiline—Somnolence—Mycophenolate mofetil—systemic scleroderma	6.84e-05	0.000271	CcSEcCtD
Selegiline—Drowsiness—Methotrexate—systemic scleroderma	6.83e-05	0.00027	CcSEcCtD
Selegiline—Rash—Azathioprine—systemic scleroderma	6.82e-05	0.00027	CcSEcCtD
Selegiline—Dermatitis—Azathioprine—systemic scleroderma	6.82e-05	0.00027	CcSEcCtD
Selegiline—Depression—Methotrexate—systemic scleroderma	6.81e-05	0.00027	CcSEcCtD
Selegiline—Flushing—Prednisone—systemic scleroderma	6.81e-05	0.000269	CcSEcCtD
Selegiline—Headache—Azathioprine—systemic scleroderma	6.78e-05	0.000268	CcSEcCtD
Selegiline—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	6.77e-05	0.000268	CcSEcCtD
Selegiline—Dizziness—Leflunomide—systemic scleroderma	6.76e-05	0.000267	CcSEcCtD
Selegiline—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	6.69e-05	0.000265	CcSEcCtD
Selegiline—Diarrhoea—Mycophenolic acid—systemic scleroderma	6.67e-05	0.000264	CcSEcCtD
Selegiline—Stomatitis—Methotrexate—systemic scleroderma	6.66e-05	0.000263	CcSEcCtD
Selegiline—Angiopathy—Prednisone—systemic scleroderma	6.66e-05	0.000263	CcSEcCtD
Selegiline—Conjunctivitis—Methotrexate—systemic scleroderma	6.64e-05	0.000263	CcSEcCtD
Selegiline—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	6.64e-05	0.000263	CcSEcCtD
Selegiline—Pain—Mycophenolate mofetil—systemic scleroderma	6.58e-05	0.00026	CcSEcCtD
Selegiline—Constipation—Mycophenolate mofetil—systemic scleroderma	6.58e-05	0.00026	CcSEcCtD
Selegiline—Arrhythmia—Prednisone—systemic scleroderma	6.56e-05	0.000259	CcSEcCtD
Selegiline—Sweating—Methotrexate—systemic scleroderma	6.55e-05	0.000259	CcSEcCtD
Selegiline—Haematuria—Methotrexate—systemic scleroderma	6.52e-05	0.000258	CcSEcCtD
Selegiline—Vomiting—Leflunomide—systemic scleroderma	6.5e-05	0.000257	CcSEcCtD
Selegiline—Alopecia—Prednisone—systemic scleroderma	6.49e-05	0.000257	CcSEcCtD
Selegiline—Hypersensitivity—Lisinopril—systemic scleroderma	6.47e-05	0.000256	CcSEcCtD
Selegiline—Hepatobiliary disease—Methotrexate—systemic scleroderma	6.46e-05	0.000256	CcSEcCtD
Selegiline—Dizziness—Mycophenolic acid—systemic scleroderma	6.45e-05	0.000255	CcSEcCtD
Selegiline—Epistaxis—Methotrexate—systemic scleroderma	6.45e-05	0.000255	CcSEcCtD
Selegiline—Rash—Leflunomide—systemic scleroderma	6.44e-05	0.000255	CcSEcCtD
Selegiline—Dermatitis—Leflunomide—systemic scleroderma	6.44e-05	0.000255	CcSEcCtD
Selegiline—Mental disorder—Prednisone—systemic scleroderma	6.43e-05	0.000254	CcSEcCtD
Selegiline—Nausea—Azathioprine—systemic scleroderma	6.43e-05	0.000254	CcSEcCtD
Selegiline—Headache—Leflunomide—systemic scleroderma	6.4e-05	0.000253	CcSEcCtD
Selegiline—Erythema—Prednisone—systemic scleroderma	6.39e-05	0.000253	CcSEcCtD
Selegiline—Malnutrition—Prednisone—systemic scleroderma	6.39e-05	0.000253	CcSEcCtD
Selegiline—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	6.34e-05	0.000251	CcSEcCtD
Selegiline—Asthenia—Lisinopril—systemic scleroderma	6.3e-05	0.000249	CcSEcCtD
Selegiline—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	6.29e-05	0.000249	CcSEcCtD
Selegiline—Pruritus—Lisinopril—systemic scleroderma	6.21e-05	0.000246	CcSEcCtD
Selegiline—Vomiting—Mycophenolic acid—systemic scleroderma	6.2e-05	0.000245	CcSEcCtD
Selegiline—Rash—Mycophenolic acid—systemic scleroderma	6.15e-05	0.000243	CcSEcCtD
Selegiline—Dermatitis—Mycophenolic acid—systemic scleroderma	6.14e-05	0.000243	CcSEcCtD
Selegiline—Hepatitis—Methotrexate—systemic scleroderma	6.13e-05	0.000243	CcSEcCtD
Selegiline—Urticaria—Mycophenolate mofetil—systemic scleroderma	6.11e-05	0.000242	CcSEcCtD
Selegiline—Headache—Mycophenolic acid—systemic scleroderma	6.11e-05	0.000242	CcSEcCtD
Selegiline—Pharyngitis—Methotrexate—systemic scleroderma	6.09e-05	0.000241	CcSEcCtD
Selegiline—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	6.08e-05	0.000241	CcSEcCtD
Selegiline—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	6.08e-05	0.000241	CcSEcCtD
Selegiline—Nausea—Leflunomide—systemic scleroderma	6.07e-05	0.00024	CcSEcCtD
Selegiline—Urinary tract disorder—Methotrexate—systemic scleroderma	6.06e-05	0.00024	CcSEcCtD
Selegiline—Vision blurred—Prednisone—systemic scleroderma	6.02e-05	0.000238	CcSEcCtD
Selegiline—Urethral disorder—Methotrexate—systemic scleroderma	6.01e-05	0.000238	CcSEcCtD
Selegiline—Diarrhoea—Lisinopril—systemic scleroderma	6.01e-05	0.000238	CcSEcCtD
Selegiline—Ill-defined disorder—Prednisone—systemic scleroderma	5.93e-05	0.000235	CcSEcCtD
Selegiline—Visual impairment—Methotrexate—systemic scleroderma	5.91e-05	0.000234	CcSEcCtD
Selegiline—Anaemia—Prednisone—systemic scleroderma	5.91e-05	0.000234	CcSEcCtD
Selegiline—Agitation—Prednisone—systemic scleroderma	5.87e-05	0.000232	CcSEcCtD
Selegiline—Dizziness—Lisinopril—systemic scleroderma	5.81e-05	0.00023	CcSEcCtD
Selegiline—Nausea—Mycophenolic acid—systemic scleroderma	5.79e-05	0.000229	CcSEcCtD
Selegiline—Malaise—Prednisone—systemic scleroderma	5.76e-05	0.000228	CcSEcCtD
Selegiline—Vertigo—Prednisone—systemic scleroderma	5.74e-05	0.000227	CcSEcCtD
Selegiline—Syncope—Prednisone—systemic scleroderma	5.73e-05	0.000227	CcSEcCtD
Selegiline—Tinnitus—Methotrexate—systemic scleroderma	5.72e-05	0.000226	CcSEcCtD
Selegiline—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	5.67e-05	0.000224	CcSEcCtD
Selegiline—Loss of consciousness—Prednisone—systemic scleroderma	5.62e-05	0.000222	CcSEcCtD
Selegiline—Vomiting—Lisinopril—systemic scleroderma	5.58e-05	0.000221	CcSEcCtD
Selegiline—Angiopathy—Methotrexate—systemic scleroderma	5.57e-05	0.00022	CcSEcCtD
Selegiline—Rash—Lisinopril—systemic scleroderma	5.54e-05	0.000219	CcSEcCtD
Selegiline—Convulsion—Prednisone—systemic scleroderma	5.54e-05	0.000219	CcSEcCtD
Selegiline—Dermatitis—Lisinopril—systemic scleroderma	5.53e-05	0.000219	CcSEcCtD
Selegiline—Asthenia—Mycophenolate mofetil—systemic scleroderma	5.52e-05	0.000218	CcSEcCtD
Selegiline—Hypertension—Prednisone—systemic scleroderma	5.52e-05	0.000218	CcSEcCtD
Selegiline—Chills—Methotrexate—systemic scleroderma	5.5e-05	0.000218	CcSEcCtD
Selegiline—Headache—Lisinopril—systemic scleroderma	5.5e-05	0.000218	CcSEcCtD
Selegiline—Pruritus—Mycophenolate mofetil—systemic scleroderma	5.44e-05	0.000215	CcSEcCtD
Selegiline—Arthralgia—Prednisone—systemic scleroderma	5.44e-05	0.000215	CcSEcCtD
Selegiline—Myalgia—Prednisone—systemic scleroderma	5.44e-05	0.000215	CcSEcCtD
Selegiline—Anxiety—Prednisone—systemic scleroderma	5.42e-05	0.000214	CcSEcCtD
Selegiline—Alopecia—Methotrexate—systemic scleroderma	5.42e-05	0.000214	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	5.4e-05	0.000214	CcSEcCtD
Selegiline—Discomfort—Prednisone—systemic scleroderma	5.37e-05	0.000213	CcSEcCtD
Selegiline—Mental disorder—Methotrexate—systemic scleroderma	5.37e-05	0.000213	CcSEcCtD
Selegiline—Erythema—Methotrexate—systemic scleroderma	5.34e-05	0.000211	CcSEcCtD
Selegiline—Malnutrition—Methotrexate—systemic scleroderma	5.34e-05	0.000211	CcSEcCtD
Selegiline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	5.26e-05	0.000208	CcSEcCtD
Selegiline—Dysgeusia—Methotrexate—systemic scleroderma	5.23e-05	0.000207	CcSEcCtD
Selegiline—Nausea—Lisinopril—systemic scleroderma	5.22e-05	0.000206	CcSEcCtD
Selegiline—Oedema—Prednisone—systemic scleroderma	5.22e-05	0.000206	CcSEcCtD
Selegiline—Infection—Prednisone—systemic scleroderma	5.18e-05	0.000205	CcSEcCtD
Selegiline—Back pain—Methotrexate—systemic scleroderma	5.17e-05	0.000204	CcSEcCtD
Selegiline—Shock—Prednisone—systemic scleroderma	5.13e-05	0.000203	CcSEcCtD
Selegiline—Nervous system disorder—Prednisone—systemic scleroderma	5.11e-05	0.000202	CcSEcCtD
Selegiline—Tachycardia—Prednisone—systemic scleroderma	5.09e-05	0.000201	CcSEcCtD
Selegiline—Dizziness—Mycophenolate mofetil—systemic scleroderma	5.09e-05	0.000201	CcSEcCtD
Selegiline—Skin disorder—Prednisone—systemic scleroderma	5.07e-05	0.0002	CcSEcCtD
Selegiline—Hyperhidrosis—Prednisone—systemic scleroderma	5.04e-05	0.000199	CcSEcCtD
Selegiline—Vision blurred—Methotrexate—systemic scleroderma	5.03e-05	0.000199	CcSEcCtD
Selegiline—Anorexia—Prednisone—systemic scleroderma	4.97e-05	0.000197	CcSEcCtD
Selegiline—Ill-defined disorder—Methotrexate—systemic scleroderma	4.95e-05	0.000196	CcSEcCtD
Selegiline—Anaemia—Methotrexate—systemic scleroderma	4.94e-05	0.000195	CcSEcCtD
Selegiline—Vomiting—Mycophenolate mofetil—systemic scleroderma	4.89e-05	0.000193	CcSEcCtD
Selegiline—Rash—Mycophenolate mofetil—systemic scleroderma	4.85e-05	0.000192	CcSEcCtD
Selegiline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	4.85e-05	0.000192	CcSEcCtD
Selegiline—Headache—Mycophenolate mofetil—systemic scleroderma	4.82e-05	0.000191	CcSEcCtD
Selegiline—Malaise—Methotrexate—systemic scleroderma	4.82e-05	0.00019	CcSEcCtD
Selegiline—Vertigo—Methotrexate—systemic scleroderma	4.8e-05	0.00019	CcSEcCtD
Selegiline—Leukopenia—Methotrexate—systemic scleroderma	4.78e-05	0.000189	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Prednisone—systemic scleroderma	4.75e-05	0.000188	CcSEcCtD
Selegiline—Insomnia—Prednisone—systemic scleroderma	4.72e-05	0.000187	CcSEcCtD
Selegiline—Paraesthesia—Prednisone—systemic scleroderma	4.68e-05	0.000185	CcSEcCtD
Selegiline—Cough—Methotrexate—systemic scleroderma	4.66e-05	0.000184	CcSEcCtD
Selegiline—Convulsion—Methotrexate—systemic scleroderma	4.63e-05	0.000183	CcSEcCtD
Selegiline—Dyspepsia—Prednisone—systemic scleroderma	4.59e-05	0.000182	CcSEcCtD
Selegiline—Nausea—Mycophenolate mofetil—systemic scleroderma	4.57e-05	0.000181	CcSEcCtD
Selegiline—Arthralgia—Methotrexate—systemic scleroderma	4.55e-05	0.00018	CcSEcCtD
Selegiline—Myalgia—Methotrexate—systemic scleroderma	4.55e-05	0.00018	CcSEcCtD
Selegiline—Chest pain—Methotrexate—systemic scleroderma	4.55e-05	0.00018	CcSEcCtD
Selegiline—Decreased appetite—Prednisone—systemic scleroderma	4.53e-05	0.000179	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	4.52e-05	0.000179	CcSEcCtD
Selegiline—Fatigue—Prednisone—systemic scleroderma	4.5e-05	0.000178	CcSEcCtD
Selegiline—Discomfort—Methotrexate—systemic scleroderma	4.49e-05	0.000178	CcSEcCtD
Selegiline—Constipation—Prednisone—systemic scleroderma	4.46e-05	0.000176	CcSEcCtD
Selegiline—Confusional state—Methotrexate—systemic scleroderma	4.39e-05	0.000174	CcSEcCtD
Selegiline—Infection—Methotrexate—systemic scleroderma	4.33e-05	0.000171	CcSEcCtD
Selegiline—Feeling abnormal—Prednisone—systemic scleroderma	4.3e-05	0.00017	CcSEcCtD
Selegiline—Nervous system disorder—Methotrexate—systemic scleroderma	4.27e-05	0.000169	CcSEcCtD
Selegiline—Thrombocytopenia—Methotrexate—systemic scleroderma	4.27e-05	0.000169	CcSEcCtD
Selegiline—Gastrointestinal pain—Prednisone—systemic scleroderma	4.26e-05	0.000169	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—systemic scleroderma	4.23e-05	0.000167	CcSEcCtD
Selegiline—Hyperhidrosis—Methotrexate—systemic scleroderma	4.21e-05	0.000167	CcSEcCtD
Selegiline—Anorexia—Methotrexate—systemic scleroderma	4.15e-05	0.000164	CcSEcCtD
Selegiline—Urticaria—Prednisone—systemic scleroderma	4.14e-05	0.000164	CcSEcCtD
Selegiline—Body temperature increased—Prednisone—systemic scleroderma	4.12e-05	0.000163	CcSEcCtD
Selegiline—Abdominal pain—Prednisone—systemic scleroderma	4.12e-05	0.000163	CcSEcCtD
Selegiline—Hypotension—Methotrexate—systemic scleroderma	4.07e-05	0.000161	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.97e-05	0.000157	CcSEcCtD
Selegiline—Insomnia—Methotrexate—systemic scleroderma	3.94e-05	0.000156	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—systemic scleroderma	3.91e-05	0.000155	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—systemic scleroderma	3.89e-05	0.000154	CcSEcCtD
Selegiline—Somnolence—Methotrexate—systemic scleroderma	3.87e-05	0.000153	CcSEcCtD
Selegiline—Hypersensitivity—Prednisone—systemic scleroderma	3.84e-05	0.000152	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—systemic scleroderma	3.84e-05	0.000152	CcSEcCtD
Selegiline—Decreased appetite—Methotrexate—systemic scleroderma	3.79e-05	0.00015	CcSEcCtD
Selegiline—Gastrointestinal disorder—Methotrexate—systemic scleroderma	3.76e-05	0.000149	CcSEcCtD
Selegiline—Fatigue—Methotrexate—systemic scleroderma	3.76e-05	0.000149	CcSEcCtD
Selegiline—Asthenia—Prednisone—systemic scleroderma	3.74e-05	0.000148	CcSEcCtD
Selegiline—Pain—Methotrexate—systemic scleroderma	3.73e-05	0.000147	CcSEcCtD
Selegiline—Pruritus—Prednisone—systemic scleroderma	3.69e-05	0.000146	CcSEcCtD
Selegiline—Feeling abnormal—Methotrexate—systemic scleroderma	3.59e-05	0.000142	CcSEcCtD
Selegiline—Diarrhoea—Prednisone—systemic scleroderma	3.57e-05	0.000141	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—systemic scleroderma	3.56e-05	0.000141	CcSEcCtD
Selegiline—Urticaria—Methotrexate—systemic scleroderma	3.46e-05	0.000137	CcSEcCtD
Selegiline—Dizziness—Prednisone—systemic scleroderma	3.45e-05	0.000136	CcSEcCtD
Selegiline—Abdominal pain—Methotrexate—systemic scleroderma	3.45e-05	0.000136	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—systemic scleroderma	3.45e-05	0.000136	CcSEcCtD
Selegiline—Vomiting—Prednisone—systemic scleroderma	3.32e-05	0.000131	CcSEcCtD
Selegiline—Rash—Prednisone—systemic scleroderma	3.29e-05	0.00013	CcSEcCtD
Selegiline—Dermatitis—Prednisone—systemic scleroderma	3.29e-05	0.00013	CcSEcCtD
Selegiline—Headache—Prednisone—systemic scleroderma	3.27e-05	0.000129	CcSEcCtD
Selegiline—Hypersensitivity—Methotrexate—systemic scleroderma	3.21e-05	0.000127	CcSEcCtD
Selegiline—Asthenia—Methotrexate—systemic scleroderma	3.13e-05	0.000124	CcSEcCtD
Selegiline—Nausea—Prednisone—systemic scleroderma	3.1e-05	0.000123	CcSEcCtD
Selegiline—Pruritus—Methotrexate—systemic scleroderma	3.08e-05	0.000122	CcSEcCtD
Selegiline—Diarrhoea—Methotrexate—systemic scleroderma	2.98e-05	0.000118	CcSEcCtD
Selegiline—Dizziness—Methotrexate—systemic scleroderma	2.88e-05	0.000114	CcSEcCtD
Selegiline—Vomiting—Methotrexate—systemic scleroderma	2.77e-05	0.00011	CcSEcCtD
Selegiline—Rash—Methotrexate—systemic scleroderma	2.75e-05	0.000109	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—systemic scleroderma	2.75e-05	0.000109	CcSEcCtD
Selegiline—Headache—Methotrexate—systemic scleroderma	2.73e-05	0.000108	CcSEcCtD
Selegiline—Nausea—Methotrexate—systemic scleroderma	2.59e-05	0.000102	CcSEcCtD
